|
Contact
|
Newsletter
|
Deutsch
Home
Subgroups
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Bayer Industry Services / Currenta
Topics
Business & Finance
Research & Innovation
Products
Responsible Care
Social Responsibility
Bayer People
Europe
North America
Asia & Pacific
Central-/Latin America
Africa & Middle East
Press Contact
Bayer AG
(Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Photo-Service
Biographies
Board of Management
Subgroups
Speeches
Photos
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Bayer Industry Services / Currenta
Education and Training
Research
Locations
Environmental Protection
TV Service
Business & Finance
Research & Innovation
Products
Responsible Care
Social Responsibility
Bayer People
Europe
North America
Asia & Pacific
Central-/Latin America
Africa & Middle East
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Bayer Industry Services / Currenta
Special Interest
Investor Relations
Jobs and Career
Sports
General Conditions of Use
Privacy Statement
Imprint
Topics
Products
|
1 - 20
|
21 - 40
|
41 - 60
|
61 - 80
|
81 - 97
|
|
Monday - June 30, 2008
Venous Blood Clot Prevention after Knee and Hip Replacement Surgery:
Rivaroxaban is First Novel Oral Anticoagulant to Significantly Reduce the Composite Outcome of Symptomatic VTE and Death
Rivaroxaban shows superior efficacy to enoxaparin for this clinical outcome with a comparable safety profile / Pre-specified analysis of pooled data from RECORD 1-3 studies involving nearly 10,000 patients
Tuesday - June 24, 2008
Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United States
Appeal of court decision invalidating Yasmin patent will continue / Further growth of Bayer’s Women’s Healthcare Business Unit expected
Thursday - June 12, 2008
Bayer MaterialScience raises price for MDI
Monday - June 2, 2008
New Nexavar® Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology (ASCO) Annual Meeting
Friday - May 30, 2008
Prevention of Thromboembolism after Knee Replacement Surgery:
Rivaroxaban One Tablet/Once-Daily Superior to Twice-Daily Injectable Enoxaparin in Preventing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
Rivaroxaban is First Oral Anticoagulant to Achieve Superior Efficacy over the Twice-Daily Injection of Enoxaparin while Maintaining Low Major Bleeding Rates / RECORD4 Confirms Results of RECORD1, 2 and 3 / U.S. Submission Planned for mid 2008 / Prof. Turpie: “Rivaroxaban has the potential to revolutionize the way we prevent the formation of dangerous blood clots”
Thursday - May 29, 2008
UEFA EURO 2008™:
Soccer ball with goose bumps
New surface structure of the “EUROPASS” was realized with Impranil®
Thursday - May 29, 2008
Collaboration with adidas
Bayer MaterialScience sets the ball rolling
The high-performance Impranil® coating takes the lead again at the European Championship
Monday - May 26, 2008
Bayer MaterialScience works on materials for robotics
Tidy up? My robot’s done it already!
The wrinkle-free polyurethane skin for service robots
Tuesday - May 6, 2008
Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe
Wednesday - April 30, 2008
New production process for natural oil polyols for rigid polyurethane foams
Optimized utilization of renewable raw materials
Promising potential for rigid thermal insulation applications
Monday - April 21, 2008
Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®
Thursday - April 17, 2008
Baycusan® C product line:
Five new ingredients for looking great
Presentation by Dr. Sophie Viala at the In-Cosmetics trade show
Wednesday - April 16, 2008
Patent infringement lawsuit against Chinese supplier:
Bayer CropScience to enforce its Mefenpyr patent
Intellectual property (IP) rights are the basis for innovation
Tuesday - April 15, 2008
Study on sandwich structures in the construction sector
Translucent design elements for interiors
Thursday - April 10, 2008
New polyurethane coatings for catheters, endoscopes and more:
Reduced friction for less pain
Latest research and development results presented at the “ECC Medical Coatings and Adhesives” conference
Tuesday - April 8, 2008
Wheelchairs and wheelbarrows run smoothly on tires made of polyurethane foam
No more flat tires
Innovative production technology, long service life
Thursday - April 3, 2008
Bayer MaterialScience cooperates with Clariant Masterbatches
Carbon nanotubes for new thermoplastic materials
Long-term cooperation is the goal
Tuesday - April 1, 2008
Packaging machinery that’s fully packaged in plastic
The polyurethane integral skin foam is easy to mold, lightweight, robust, heat-resistant and can be processed cost-effectively
Friday - March 7, 2008
Bayer MaterialScience improves IMPACT technology for producing polyether polyols
Increased capacity and higher quality
Products are used in raw materials for high-grade polyurethane adhesives and sealants
Thursday - March 6, 2008
Partnership with Hyundai on the "i-mode" concept car
Premiere at the 78th International Motor Show in Geneva
|
1 - 20
|
21 - 40
|
41 - 60
|
61 - 80
|
81 - 97
|
|
Print page
Search
Advanced Search
Publications
Annual Report 2007
Stockholder's Newsletter
research – The Bayer Scientific Magazine
Sustainable Development Report 2007
Publications Overview
Newsletter
We will keep you informed about the latest news.
Events
Wednesday, July 30, 2008
Q2 2008 Interim Report
Contact:
Günter Forneck
Additional Press Events
Investor Relations Events
Sport Events
BayKomm Events
Download Center - Selection
Your selection:
0
Download(s)